Lisa K. Peterson
No Rating Available
(Learn About Our Rating System)

Lisa K. Peterson, PhD

Languages spoken: English

  • Dr. Peterson is an Associate Professor of Pathology at the University of Utah School of Medicine and a Medical Director in the Immunology division at ARUP Laboratories, where she oversees testing that aids in the diagnosis of autoimmunity and immune deficiency.

    Dr. Peterson received her PhD in Experimental Pathology from the University of Utah and completed a postdoctoral fellowship in the Department of Immunology at National Jewish Health and the University of Colorado School of Medicine in Denver, both with an emphasis on autoimmunity and lymphocyte effector function. Dr. Peterson continued her training with a clinical immunology fellowship at the University of Utah. After completing her fellowship, she was board-certified in Medical Laboratory Immunology by the American Board of Medical Laboratory Immunology. Dr. Peterson’s research interests include cellular immunology and autoimmune immunology, with a focus on autoimmune neurology.

    Specialties

    • Pathology, Clinical

    Board Certification

    American Board of Medical Laboratory Immunology

  • Dr. Peterson is an Associate Professor of Pathology at the University of Utah School of Medicine and a Medical Director in the Immunology division at ARUP Laboratories, where she oversees testing that aids in the diagnosis of autoimmunity and immune deficiency.

    Dr. Peterson received her PhD in Experimental Pathology from the University of Utah and completed a postdoctoral fellowship in the Department of Immunology at National Jewish Health and the University of Colorado School of Medicine in Denver, both with an emphasis on autoimmunity and lymphocyte effector function. Dr. Peterson continued her training with a clinical immunology fellowship at the University of Utah. After completing her fellowship, she was board-certified in Medical Laboratory Immunology by the American Board of Medical Laboratory Immunology. Dr. Peterson’s research interests include cellular immunology and autoimmune immunology, with a focus on autoimmune neurology.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Medical Laboratory Immunology

    Education history

    Fellowship Clinical Immunology - University of Utah School of Medicine Fellow
    Immunology - University of Colorado Denver/National Jewish Health Postdoctoral Fellow
    Doctoral Training Experimental Pathology - University of Utah School of Medicine Ph.D.
    Biology; Chemistry Minor - University of Utah B.S.

    Selected Publications

    Journal Article

    1. Hoshina Y, Abbatemarco JR, Rodenbeck SJ, Poon JT, Liu SC, Paz Soldan MM, Greenlee JE, Rose JW, Peterson LK, Johnson L, Delic A, Smith TL, Clardy SL (2024). Matched oligoclonal bands: Diagnostic utility and clinical characteristics. Ann Clin Transl Neurol. (Read full article)
    2. Martins TB, Hill HR, Peterson LK (2024). Evaluating patient immunocompetence through antibody response to pneumococcal polysaccharide vaccine using a newly developed 23 serotype multiplexed assay. Clin Immunol, 110295. (Read full article)
    3. Martins TB, Hill HR, Peterson LK (2024). Specimen type validation and establishment of normal cytokine reference intervals in cerebrospinal fluid. J Immunol Methods, 529, 113681. (Read full article)
    4. Luong K, Lozier BK, Novis CL, Smith TL, Zuromski LM, Peterson LK (2024). Comparison of three methods for the detection of antibodies against muscle-specific kinase. J Immunol Methods, 526, 113627. (Read full article)
    5. Smith TL, Haven TR, Zuromski LM, Luong K, Clardy SL, Peterson LK (2023). High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting. Front Neurol, 14, 1192644. (Read full article)
    6. Tebo AE, Peterson LK, Snyder MR, Lebiedz-Odrobina D (2023). Clinical Significance of Anti-U1 Ribonucleoprotein Antibody Is Analyte Dependent: Implications for Laboratory Reporting, Interpretation, and Interassay Correlations. Arch Pathol Lab Med. (Read full article)
    7. Peterson LK (2022). Application of vaccine response in the evaluation of patients with suspected B-cell immunodeficiency: Assessment of responses and challenges with interpretation. J Immunol Methods, 510, 113350. (Read full article)
    8. Kulasingam V, Booth RA, Peterson LK, Snyder MR (2021). The Journal of Applied Laboratory Medicine Special Issue on Autoimmune Diagnostics. J Appl Lab Med, 7(1), 1-2. (Read full article)
    9. Williams JP, Abbatemarco JR, Galli JJ, Rodenbeck SJ, Peterson LK, Haven TR, Street M, Rose JW, Greenlee JE, Soldan MMP, Clardy SL (2021). Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay. Mult Scler Int, 2021, 8692328. (Read full article)
    10. Lozier BK, Haven TR, Tebo AE, Peterson LK (2021). Performance evaluation of a radioimmunoprecipitation assay for the detection of N-type voltage-gated calcium channel antibodies. J Immunol Methods, 496, 113102. (Read full article)
    11. Izadi N, Knight V, Strand M, Hill HR, Peterson LK, Hauk PJ (2021). An enzyme-linked immunospot assay to evaluate Pneumovax response when on intravenous immunoglobulin. Ann Allergy Asthma Immunol, 128, 61-67.e4. (Read full article)
    12. Liu BM, Martins TB, Peterson LK, Hill HR (2021). Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review. Cytokine, 142, 155478. (Read full article)
    13. Jaffe SL, Carlson NG, Peterson LK, Greenlee JE (2020). Treatment-responsive primary autoimmune cerebellar ataxia in a patient with IgG and IgM anticerebellar antibodies. Eur J Neurol, 28(5), 1771-1773. (Read full article)
    14. Knight V, Askar MZ, Ntrivalas E, Nandiwada SL, Peterson LK, Tebo AE, Kadkhoda K, Schmitz JL, Naides SJ, Snyder MR, Sadighi Akha AA (2021). Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI). J Immunol Methods, 492, 112994. (Read full article)
    15. Tebo AE, Schmidt RL, Kadkhoda K, Peterson LK, Chan EKL, Fritzler MJ, Wener MH (2021). The antinuclear antibody HEp-2 indirect immunofluorescence assay: a survey of laboratory performance, pattern recognition and interpretation. Auto Immun Highlights, 12(1), 4. (Read full article)
    16. Peterson LK, Tebo AE, Wener MH, Copple SS, Fritzler MJ (2020). Assessment of antinuclear antibodies by indirect immunofluorescence assay: report from a survey by the American Association of Medical Laboratory Immunologists. Clin Chem Lab Med, 58(9), 1489-1497. (Read full article)
    17. Ravkov EV, Charlton CM, Barker AP, Hill H, Peterson LK, Slev P, Tebo A, Voelkerding KV, Wittwer CT, Heikal N, Delgado JC, Lzr-Molnr E, Kumnovics A (2019). Evaluation of Mass Cytometry in the Clinical Laboratory. Cytometry B Clin Cytom, 96(4), 266-274. (Read full article)
    18. Tuttle KD, Krovi SH, Zhang J, Bedel R, Harmacek L, Peterson LK, Dragone LL, Lefferts A, Halluszczak C, Riemondy K, Hesselberth JR, Rao A, OConnor BP, Marrack P, Scott-Browne J, Gapin L (2018). TCR signal strength controls thymic differentiation of iNKT cell subsets. Nat Commun, 9(1), 2650. (Read full article)
    19. Peterson LK, Jaskowski TD, Laulu SL, Tebo AE (2018). Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort. Immunol Res, 66(3), 431-436. (Read full article)
    20. Kushnir MM, Peterson LK, Strathmann FG (2017). Parathyroid hormone related protein concentration in human serum and CSF correlates with age. Clin Biochem, 52, 56-60. (Read full article)

    Review

    1. Walker BS, Peterson LK, Koening C, White SK, Schmidt RL, Tebo AE (2022). Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis. [Review]. Autoimmun Rev, 21(6), 103100. (Read full article)